Skip to main content
Neuropsychopharmacology logoLink to Neuropsychopharmacology
. 2020 Sep 8;45(13):2302. doi: 10.1038/s41386-020-00818-1

Retraction Note: Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors

Robert H Pietrzak 1,2, Yiyun Huang 3, Stefani Corsi-Travali 4, Ming-Qiang Zheng 3, Shu-fei Lin 3, Shannan Henry 3, Marc N Potenza 2, Daniele Piomelli 5, Richard E Carson 3, Alexander Neumeister 4,
PMCID: PMC7785013  PMID: 32901117

Retraction to: Neuropsychopharmacology 10.1038/npp.2014.110, published online 12 May 2014

The editors have retracted this article [1]. An investigation conducted by the US Office of Research Integrity (ORI) [2] concluded this article includes “falsified and/or fabricated research methods and results”.

The authors A Neumeister, H Huang, M Zheng, R E Carson, M N Potenza, R H Pietrzak, and D Piomelli have chosen not to comment on this retraction. The authors S Corsi-Travali, S-F Lin, and S Henry have not responded to correspondence about this retraction.

[1] https://www.nature.com/articles/npp2014110

[2] https://ori.hhs.gov/index.php/content/case-summary-neumeister-alexander

Footnotes

The original article can be found online at 10.1038/npp.2014.110.


Articles from Neuropsychopharmacology are provided here courtesy of Nature Publishing Group

RESOURCES